Status:
COMPLETED
Time Restricted Eating for the Treatment of Type 2 Diabetes
Lead Sponsor:
University of Illinois at Chicago
Conditions:
Diabetes Mellitus, Type 2
Obesity
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Innovative lifestyle strategies to treat type 2 diabetes (T2DM) are critically needed. At present, daily calorie restriction (CR) is the main diet prescribed to patients with T2DM for weight loss. How...
Eligibility Criteria
Inclusion
- Age 18-80 years
- BMI between 30 and 50 kg/m2
- Previously diagnosed with type 2 diabetes
- HbA1c between 6.5 and 11%
- Sedentary or lightly active
Exclusion
- HbA1c below 6.5 or greater than 11%
- Have a history of cardiovascular disease
- History of eating disorders (anorexia, bulimia, or binge eating disorder)
- Not weight stable for 3 months prior to the beginning of study (weight gain or loss \> 4%)
- Eating within less than a 10 hour window at baseline
- Perimenopausal (menses does not appear every 27-32d)
- Pregnant, or trying to become pregnant
- Night shift workers
- Smokers
Key Trial Info
Start Date :
February 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 25 2024
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT05225337
Start Date
February 10 2022
End Date
November 25 2024
Last Update
November 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois Chicago
Chicago, Illinois, United States, 60612